Back to Search
JAEDEOK KIM, LAC, PHD.
LAC, PHD.
Acupuncturist
NPI: 1144793134Individual
Specialties, Licenses & Credentials
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.
PMID 39978685·J Allergy Clin Immunol·2025
8-other
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
PMID 30097359·Lancet·2018
3-trial
Proportion of CD4CD49bLAG-3Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.
PMID 29890167·J Invest Dermatol·2018
8-other
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
PMID 28927890·J Invest Dermatol·2018
3-trial
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
PMID 28423301·N Engl J Med·2017
3-trial
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
PMID 27686018·Annu Rev Med·2017
6-review
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
PMID 27185339·J Invest Dermatol·2016
4-observational
Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions-Lessons Learned From Focus Groups.
PMID 27028481·JAMA Dermatol·2016
8-other
Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
PMID 26763436·J Invest Dermatol·2016
4-observational
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial.
PMID 25769911·J Allergy Clin Immunol·2015
2-rct
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
PMID 14707118·J Exp Med·2004
4-observational
Ureibacillus composti sp. nov. and Ureibacillus thermophilus sp. nov., isolated from livestock-manure composts.
PMID 18048747·Int J Syst Evol Microbiol·2007
7-preclinical
Microbial diversity in natural asphalts of the Rancho La Brea Tar Pits.
PMID 17416692·Appl Environ Microbiol·2007
8-other
Marinobacter koreensis sp. nov., isolated from sea sand in Korea.
PMID 17082406·Int J Syst Evol Microbiol·2006
8-other
Loktanella koreensis sp. nov., isolated from sea sand in Korea.
PMID 16957121·Int J Syst Evol Microbiol·2006
8-other
Pseudoxanthomonas suwonensis sp. nov., isolated from cotton waste composts.
PMID 16514045·Int J Syst Evol Microbiol·2006
8-other
Genetically engineered elastin-protein A fusion as a universal platform for homogeneous, phase-separation immunoassay.
PMID 15828763·Anal Chem·2005
8-other
Temperature-triggered purification of antibodies.
PMID 15800861·Biotechnol Bioeng·2005
4-observational
Phylogenetic analysis of the genera Bradyrhizobium, Mesorhizobium, Rhizobium and Sinorhizobium on the basis of 16S rRNA gene and internally transcribed spacer region sequences.
PMID 15653885·Int J Syst Evol Microbiol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3858 CHICAGO AVE
RIVERSIDE, CA 92507 - Phone
- (657) 252-1560
Quick Facts
- NPI
- 1144793134
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile